March marks TB Awareness Month, highlighting the ongoing global challenge of tuberculosis. The Independent Community Pharmacy Association sheds light on the importance of early detection, treatment, ...
Objective: Multidrug-resistant tuberculosis (MDR-TB) remains a global public health challenge, complicating treatment strategies and requiring advanced therapeutic approaches. The persistence of ...
Experts have told Medscape News Europe that extensively drug-resistant tuberculosis (XDR-TB) is emerging as a serious threat in Europe, describing it as a “quietly growing monster” that could ...
Across Europe, tuberculosis (TB) is once again raising alarm, particularly the extensively drug-resistant form (XDR-TB), which is proving as deadly as before antibiotics were discovered. A large ...
Introduction Tuberculosis (TB) remains a critical global public health challenge, and there is an urgent need to improve the diagnosis and management of post-TB lung disease (PTLD). We aimed to ...
Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic Biomedical Research Center, University Hospital Hradec Kralove, Sokolska ...
According to Coherent Market Insights, the global Tuberculosis Therapeutics Market is estimated to be valued at USD 2.11 Bn in 2025 and is expected to reach USD 3.50 Bn by 2032, exhibiting a compound ...
Background: Tuberculosis (TB) remains the leading cause of death from a single infectious agent. However, there is limited quantitative evidence on the impact of urbanization on TB burden. We aimed to ...
NEW findings from a European cohort study reveal dismal treatment success rates for extensively drug-resistant tuberculosis (XDR-TB), underscoring urgent gaps in regimen design and access to effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results